• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prophylactic Hemodialysis for Protection Against Gadolinium-Induced Nephrogenic Systemic Fibrosis: A Doll's House.

作者信息

Yee Jerry

机构信息

Division of Nephrology and Hypertension, Department of Internal Medicine, Henry Ford Hospital, Detroit, MI.

出版信息

Adv Chronic Kidney Dis. 2017 May;24(3):133-135. doi: 10.1053/j.ackd.2017.03.007.

DOI:10.1053/j.ackd.2017.03.007
PMID:28501073
Abstract
摘要

相似文献

1
Prophylactic Hemodialysis for Protection Against Gadolinium-Induced Nephrogenic Systemic Fibrosis: A Doll's House.预防钆诱导的肾源性系统性纤维化的预防性血液透析：一个玩偶之家。
Adv Chronic Kidney Dis. 2017 May;24(3):133-135. doi: 10.1053/j.ackd.2017.03.007.
2
Nephrogenic systemic fibrosis: possible mechanisms and imaging management strategies.肾源性系统性纤维化：可能的机制及影像学管理策略。
J Magn Reson Imaging. 2008 Oct;28(4):797-804. doi: 10.1002/jmri.21521.
3
Gadolinium-associated nephrogenic systemic fibrosis.钆相关的肾源性系统性纤维化。
Am Fam Physician. 2009 Oct 1;80(7):711-4.
4
Nephrogenic systemic fibrosis: the need for accurate case reporting.肾源性系统性纤维化：准确病例报告的必要性。
J Magn Reson Imaging. 2009 May;29(5):1240; author reply 1241. doi: 10.1002/jmri.21741.
5
The Risk of Nephrogenic Systemic Fibrosis in Group II and III Gadolinium-Based Contrast Agents.II 类和 III 类钆基造影剂引发肾源性系统性纤维化的风险
Can Assoc Radiol J. 2020 Nov;71(4):536. doi: 10.1177/0846537119888408. Epub 2020 Jan 31.
6
Gadolinium-induced NSF claim resolved in favor of plaintiff.钆诱导的 NSF 索赔案以原告胜诉告终。
J Med Assoc Ga. 2012;101(3):32-3.
7
Nephrogenic systemic fibrosis and gadolinium: a cautionary tale in the molecular imaging era.肾源性系统性纤维化与钆对比剂：分子成像时代的一则警示故事
J Med Imaging Radiat Oncol. 2008 Aug;52(4):305-6. doi: 10.1111/j.1440-1673.2008.01983.x.
8
Correction to the relative risk calculation for gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis.钆增强磁共振成像与肾源性系统性纤维化相对风险计算的校正
Radiology. 2010 Apr;255(1):307-8; author reply 308. doi: 10.1148/radiol.091726.
9
[Nephrogenic systemic fibrosis and gadolinium contrast agents].[肾源性系统性纤维化与钆对比剂]
Med Clin (Barc). 2011 May 21;136(14):643-5. doi: 10.1016/j.medcli.2010.11.027. Epub 2011 Mar 11.
10
Safety of magnetic resonance contrast media: a review with special focus on nephrogenic systemic fibrosis.磁共振造影剂的安全性：特别关注肾源性系统性纤维化的综述
Top Magn Reson Imaging. 2015 Feb;24(1):57-65. doi: 10.1097/RMR.0b013e3182a14e79.

引用本文的文献

1
Contrast-induced acute kidney injury and nephrogenic systemic fibrosis in children.儿童对比剂诱导的急性肾损伤和肾源性系统性纤维化
Pediatr Nephrol. 2025 Aug 11. doi: 10.1007/s00467-025-06916-w.
2
Safe and Informed Use of Gadolinium-Based Contrast Agent in Body Magnetic Resonance Imaging: Where We Were and Where We Are.钆基造影剂在体部磁共振成像中的安全与合理使用：我们的过去与现在
J Clin Med. 2024 Apr 10;13(8):2193. doi: 10.3390/jcm13082193.
3
Nephrogenic Systemic Fibrosis in Patients with Chronic Kidney Disease after the Use of Gadolinium-Based Contrast Agents: A Review for the Cardiovascular Imager.
慢性肾脏病患者使用钆基造影剂后发生的肾源性系统性纤维化：心血管影像医师综述
Diagnostics (Basel). 2022 Jul 28;12(8):1816. doi: 10.3390/diagnostics12081816.
4
Gadolinium-Based Contrast Agents: Updates and Answers to Typical Questions Regarding Gadolinium Use.钆基造影剂：有关钆使用的常见问题的最新解答。
Tex Heart Inst J. 2022 May 1;49(3). doi: 10.14503/THIJ-21-7680.
5
Use of Intravenous Gadolinium-Based Contrast Media in Patients With Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation.基于钆的静脉造影剂在肾病患者中的应用：美国放射学会和美国国家肾脏基金会的共识声明
Kidney Med. 2020 Nov 10;3(1):142-150. doi: 10.1016/j.xkme.2020.10.001. eCollection 2021 Jan-Feb.
6
Gadolinium-based contrast agents: why nephrologists need to be concerned.镧系元素类造影剂：肾科医生为何需关注此类药物。
Curr Opin Nephrol Hypertens. 2019 Mar;28(2):154-162. doi: 10.1097/MNH.0000000000000475.